Serum Institute of India (SII)
Serum Institute has sought indemnity against legal proceedings linked to the use of its vaccines in India as well as the government's nod to produce Russian Covid-19 jab Sputnik V in this country. "Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it," a company official told the local media on Thursday. Read:India's COVID-19 tally rises to 28,441,986 Serum's demand comes in the wake of media reports that Prime Minister Narendra Modi's government is planning to grant legal protection to foreign Covid vaccine makers Pfizer and Moderna. The vaccine maker has also sought permission from the country's drugs controller for a test licence to manufacture Sputnik V shots in India. "SII put up an application to the Drugs Controller General of India on Wednesday, seeking permission to manufacture Sputnik V in India," another company official told the local media. Read: India to start trials on safety, efficacy of mixing Covid vaccine doses
As three Covid-19 vaccines look ready to be rolled out soon, now one question is crossing the public mind where actually Bangladesh is in the line to have one.